background image

Board of directors

[+] Chief Executive Officer of TissueGene
Woosok Lee

Woosok Lee, the President and CEO of TissueGene, brings a broad and multidisciplinary international experience to the company. In addition to his role at TissueGene, Mr. Lee currently serves as the President and CEO of Kolon Pharmaceuticals, Inc., the President and CEO of Kolon ePlatform, Inc., and the President and CEO of Kolon Life Science, Inc. Mr. Lee received his MBA from the UCLA University in Los Angeles, California, and his bachelor’s degree in Economics from the Seoul National University in Korea.

[+] Chief Executive Officer of TissueGene
Bumsup Lee, Ph.D

Bumsup Lee, DVM & PhD, President and CEO of TissueGene, joined TissueGene, Inc. in March, 2014 as Chief Operating Officer. He was the Executive Vice President and CTO of Kolon Life Science, Inc (KLS), a position he held from May 2011 to May 2017, where he was responsible for a full range of R&D, clinical, BD, and manufacturing. Prior to joining KLS, he worked for biotechs and pharmaceutical companies of Dong-A pharm, Mitokor, Syrrx, and Takeda San Diego since 1988 where he advanced multiple drug candidates to clinical stages and won commercialization in the areas of diabetes, arthritis, and cancers. He obtained his DVM and MS in pathology from Seoul National University and his PhD from Iowa State University. He was a postdoctoral fellow at the State University of New York.

[+] Chief Financial Officer of TissueGene
Soon-Wook Kweon

Soon-Wook Kweon joined TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined TissueGene, he served as the Vice President of Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

[+] Outside Director
Jangik I. Lee, PhD

In addition to his role as the Outside Director at TissueGene, Jangik I. Lee also serves as the professor of Clinical Pharmacy and Regulatory Science in Seoul National University in Korea. He received his PhD degree in Clinical Pharmaceutical Scientist Program at the School of Pharmacy in University of Pittsburgh.

[+] Statutory Auditor
Young J. Kim, PhD

Young J. Kim's extensive experience in Public Safety and emergency Management communication, command and control systems is strongly complemented and balanced with in-depth expertise in systems and software engineering & engineering management principals and processes. He founded and served as President responsible for all company operations and business development activities in Young Enterprise Systems, Inc. until 2016. He received his Doctorate in Systems Engineering and Management at George Washington University.